Guardian Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.36M Sell
10,674
-9,236
-46% -$2.55M 0.21% 80
2026
Q1
$5.89M Buy
19,910
+91
+0.5% +$27K 0.49% 53
2025
Q4
$5.82M Buy
19,819
+3,344
+20% +$909K 0.47% 54
2025
Q3
$4.38M Buy
16,475
+1,900
+13% +$517K 0.37% 67
2025
Q2
$4.02M Buy
14,575
+360
+3% +$97.9K 0.36% 69
2025
Q1
$3.72M Sell
14,215
-1,570
-10% -$387K 0.38% 72
2024
Q4
$3.62M Buy
+15,785
New +$3.63M 0.37% 68

Other funds holding CME

Guardian Partners's CME Position: Q2 2026 in Review

Guardian Partners reduced its CME Group (CME) stake by 46% in Q2 2026, selling an estimated $2.55M and leaving 10,674 shares worth $2.36M. The position accounts for 0.21% of the portfolio, ranked #80.

Guardian Partners first reported a position in CME in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.89M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Guardian Partners held 10,674 shares of CME Group worth $2.36M as of Q2 2026.
  • Guardian Partners sold 9,236 CME Group shares in Q2 2026, an estimated $2.55M.
  • CME Group made up 0.21% of Guardian Partners's portfolio in Q2 2026, its #80 holding.
  • Guardian Partners first reported a position in CME Group in Q4 2024 and has held it in 7 quarters since.
  • Guardian Partners's CME Group position peaked at $5.89M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Guardian Partners's 13F filing for Q2 2026, filed 29 Jul 2026.